newscontact us

CESCA THERAPEUTICS TO PRESENT AT THE 2017 MARCUM MICROCAP CONFERENCE

RANCHO CORDOVA, CA, June 12, 2017 – Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Dr. Xiaochun “Chris” Xu, interim chief executive officer, will present at the 2017 Marcum MicroCap Conference on Thursday, June 15, 2017, at the Grand Hyatt Hotel in New York. Dr. Xu’s presentation is scheduled to begin at 9:00 AM…(more)